# Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

> **NCT04422457** · NA · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 30 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **OTHER:** 68Ga-DX600 PET/CT

## Key facts

- **NCT ID:** NCT04422457
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-13
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04422457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04422457, "Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04422457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*